Early research (Phase 1)UnknownNCT05108012What this trial is testingNk Cell Therapy for Recurrent Glioblastoma Multiform PatientsWho this might be right forGlioblastoma MultiformRecurrent Glioblastoma Royan Institute 5
Testing effectiveness (Phase 2)Study completedNCT01120639What this trial is testingPhase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma MultiformWho this might be right forGlioblastomaCancer of Brain and Nervous SystemGlioblastoma Multiforme Stanford University 30
Not applicableStudy completedNCT01699269What this trial is testingHistopathologic Evaluation of High Grade Brain Tumors by High Order Diffusion Tensor ImagingWho this might be right forHigh Grade Brain Tumor University Hospital, Clermont-Ferrand 10
Early research (Phase 1)WithdrawnNCT00703859What this trial is testingCombining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma AHS Cancer Control Alberta
Early research (Phase 1)Study completedNCT00610571What this trial is testingPh I Oral Topotecan and Temozolomide for Patients With Malignant GliomasWho this might be right forGlioblastomaGliosarcomaAnaplastic Astrocytoma Katy Peters 62
Large-scale testing (Phase 3)Looking for participantsNCT07100730What this trial is testingStudy of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent GlioblastomaWho this might be right forNeoplastic DiseaseGlioblastomaGlioblastoma (GBM)+3 more Telix Pharmaceuticals (Innovations) Pty Limited 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT01777919What this trial is testingDisulfiram/Copper Combination In The Treatment of Newly Diagnosed Glioblastoma MultiformWho this might be right forGlioblastoma Multiforme Olympion Medical Center 32
Early research (Phase 1)Study completedNCT01833273What this trial is testingDose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVAWho this might be right forGlioblastoma Multiform (Grade IV Astrocytoma) Stony Brook University 13
Early research (Phase 1)Study completedNCT00977431What this trial is testingOpen Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma MultiformWho this might be right forGlioblastoma Boehringer Ingelheim 36
Early research (Phase 1)Looking for participantsNCT05460507What this trial is testingSafety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL TreatmentWho this might be right forGlioma Plus Therapeutics 40
Testing effectiveness (Phase 2)UnknownNCT01567202What this trial is testingStudy of DC Vaccination Against GlioblastomaWho this might be right forGliomaGlioblastoma MultiformeNeoplasms Huashan Hospital 100
Not applicableNot Yet RecruitingNCT06869577What this trial is testingA Supportive Group Intervention for Caregivers to Patients Diagnosed With a GlioblastomaWho this might be right forCaregiverGlioblastoma Multiform (Grade IV Astrocytoma) Rigshospitalet, Denmark 24
Early research (Phase 1)Looking for participantsNCT06632236What this trial is testing5G-EMERALD: Amivantamab in Malignant Brain TumoursWho this might be right forMalignant Primary GliomasGlioblastoma Multiform (Grade IV Astrocytoma)Diffuse Hemispheric Glioma, H3 G34-Mutant+1 more Institute of Cancer Research, United Kingdom 12
Testing effectiveness (Phase 2)Looking for participantsNCT01906385What this trial is testingMaximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)Who this might be right forGlioma Plus Therapeutics 55
Testing effectiveness (Phase 2)Looking for participantsNCT06630260What this trial is testing5G-RUBY: Avutometinib and Defactinib in Malignant Brain TumoursWho this might be right forGlioblastoma Multiforme (GBM)Glioblastoma Multiform (Grade IV Astrocytoma)Diffuse Hemispheric Glioma, H3 G34-Mutant+1 more Institute of Cancer Research, United Kingdom 182